Life science company Inficure Bio has been awarded millions by Vinnova to support the company’s development of a model that will help create new treatments for fibrosis.
“This money is incredibly important to us. Thanks to this investment we can now finish developing a new product”, says Sofia Mayans, CEO of Inficure Bio.
Small and medium-sized life science companies operating in the Västerbotten county in Sweden will double in numbers over the next ten years, while a vibrant scientific community will add to the growth. These are the goals set by Umeå Biotech Incubator (UBI), which is now entering a new development phase of its incubator operation in Umeå.
BioEurope Spring in Vienna with 2 486 delegates, ranging from International investors to major companies. Our business coach Helén is in Vienna representing UBI and life science in northern Sweden.
For the eleventh year in a row Umeå Biotech Incubator hosted the Biotech Umeå Investment Day (BUID) (last Thursday) at Stockholm’s Grand Hôtel, when investors from Sweden and abroad got the opportunity to meet 12 companies from Västerbotten.
UBI:s kommunikationsansvariga, Carolina Hawranek, kommer under våren lämna sin postition för att istället att forska på heltid. Vi frågar lite om hennes tid på här UBI och om flytten till Umeå.
Researchers from Quretech Bio AB (Quretech Bio) in Umeå, who were awarded a research grant of approximately SEK 25 million in the summer, have been awarded additional funding of just over SEK 17 million this autumn (made up of SEK 7.5 million from the Swedish Research Council, SEK 8 million from the Erling Persson Family Foundation and SEK 2.1 million from Umeå University).
Recently, Uman Diagnostics received national attention after making it onto the list of “Sweden’s Super Companies 2018”. Niklas Norgren explains how an idea in the lab at Umeå University grew into a company and a success story.
Hiloprobe AB has signed off on a partnership deal with a group of public and private stakeholders who have come together to back this high-potential startup. Hiloprobe is now complemented with much needed business expertise – as Mattias Pettersson from Northern Light Capital joins the board of directors, The company aims to launch their product for improved colorectal cancer diagnosis by 2020.
Inficure Bio has developed a new mouse model, the N-IF model. Mice are used as model organisms for studying human biology due to the genetic and physiological conformity between mice and humans. N-IF mice are unique as they spontaneously develop pathological fibrosis, rather than it being induced. This pathological progress is therefore more natural and provides better and faster results.
UBI Company Quretech Bio has reached a milestone in its development.
Recently, the company took its first investment capital and a cunning business development partner – a local player in Västerbotten.
After a thorough selection process, Lipum AB has been granted SEK 22 million from the EU’s Horizon 2020-initiative. This is a great leap forward for researchers who want to better quality of life for children and adults with chronic inflammatory diseases.
Umeå region’s life science companies and Umeå Biotech Incubator (UBI) have generated great successes during recent years. One of the contributing factors is the unique process that has been developed during the three-year HIBA project.
The results from the evaluation of the highly competitive national call “Projects for Better Health” were announced on March 18th. Again, two UBI-related cases are among the 22 successful applicants who receive funding. The total sum granted is 20,5 million SEK.
One year following the world’s most widespread manifestation for science we are back at it. Together with 52 other national organisations and stakeholders we argue that evidence and research are a vital part of creating the society of tomorrow.
The ninth edition of Biotech Umeå’s annual partnering event was the first ever to fill up before deadline. Around 30 Swedish and European investors met with 13 startups and early cases. Two weeks after the event participants report an impressive turnout – on average they have retained at least five active leads per company.
The first ever edition of Meet Umeå Life Sceince gathered over 70 branch experts, entrepreneurs and researchers in Stockholm. This after-work networking mingle allowed startups to connect with experienced professionals with industrial expertise and business know-how. The aim was to match our promising ideas with the skills necessary to grow successfully.
As we enter 2018, we look back at a hectic, inspiring and successful year for the incubator-related community of life science companies in Umeå. We are experiencing a surge in incoming ideas, elevated interest from the industry and a stronger demand for the incubator facilities and labs.
The Umeå-derived invention has taken nine years to go from idea to approved product for sale. Pernilla Abrahamsson, the creator of OnZurf Probe, has successfully ushered her innovation all the way from that moment of serendipity to CE-approval – the final milestone before launch.
A new national call named “Projekt för Bättre Hälsa” opens today and is a joint innovation drive from the strategic national research programmes SweLife and MedTech4Health. Collaboration is mandatory – but each applicant can land up to one million SEK in funding if successful. SweLife offers hands-on support to make that happen for your team.
The Umeå-based life science incubator commonly known as UBI is growing in both projects, plans and people. The team is now searching for a service-minded laboratory technician that can help to develop the thriving life science community growing in and around the incubator at Tvistevägen 48.
